CoChat

The economic impact of the introduction of home blood pressure measurement for the diagnosis and treatment of hypertension

Funahashi, Jin, Ohkubo, Takayoshi, Fukunaga, Hidefumi, Kikuya, Masahiro, Takada, Noriko, Asayama, Kei, Metoki, Hirohito, Obara, Taku, Inoue, Ryusuke, Hashimoto, Junichiro, Totsune, Kazuhito, Kobayashi, Makoto, Imai, Yutaka · 2006 · Blood Pressure Monitoring
Cited by 52

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

OBJECTIVES: To investigate the economic consequences resulting from introduction of home blood pressure measurement in diagnosis of hypertension instead of casual clinic blood pressure measurement. METHODS: We constructed a decision tree model using data from the Ohasama study and a Japanese national database. The Ohasama study provided the prognostic value of home blood pressure as compared with clinic blood pressure measurement. RESULTS: It is predicted that the use of home blood pressure for hypertension diagnosis results in a saving of 9.30 billion US dollars (1013.6 billion yen) in hypertension-related medical costs in Japan. Most of this was attributable to medical costs saved by avoiding the start of treatment for untreated individuals who were diagnosed as hypertensive by clinic blood pressure but whose blood pressures were in the normal range when based on home blood pressure; that is, the so called white-coat hypertension. Furthermore, it could be expected that adequate blood pressure control mediated by the change in the diagnostic method from clinic to home blood pressure measurement would improve the prognosis for hypertension. We estimated that the prevention of hypertensive complications resulted in a reduction of annual medical costs by 28 million US dollars (3.0 billion yen). In addition, stroke prevention due to adequate blood pressure control based on home blood pressure measurement reduced annual long-term care costs by 39 million US dollars (4.2 billion yen). A per-person break-even cost for introducing home blood pressure monitoring was calculated as 409 US dollars (44,580 yen). CONCLUSIONS: The introduction of home blood pressure measurement for the diagnosis and treatment of hypertension would be very effective to save costs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/01.mbp.0000217996.19839.70

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 52

Metadata

Authors
Funahashi, J., Ohkubo, T., Fukunaga, H., Kikuya, M., Takada, N., Asayama, K., Metoki, H., Obara, T., Inoue, R., Hashimoto, J., Totsune, K., Kobayashi, M., & Imai, Y.
Venue
Blood Pressure Monitoring
Published
2006-10
Volume
11
Issue
5
Pages
257-267
ISSN
1359-5237 (ISSN-L)
OpenAlex
W2053454445
Cited by
52
References
4
FWCI
3.28
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The economic impact of the introduction of home blood pressure measurement for the diagnosis and treatment of hypertension. https://app.cochat.ai/papers/10.1097/01.mbp.0000217996.19839.70
The paper
Funahashi, J., Ohkubo, T., Fukunaga, H., Kikuya, M., Takada, N., Asayama, K., Metoki, H., Obara, T., Inoue, R., Hashimoto, J., Totsune, K., Kobayashi, M., & Imai, Y. (2006). The economic impact of the introduction of home blood pressure measurement for the diagnosis and treatment of hypertension. Blood Pressure Monitoring. https://doi.org/10.1097/01.mbp.0000217996.19839.70

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.